With Covid-19 revenues declining, we believe hospital operators are likely to be out of favour in 2022F, but they are defensive amid geopolitical tensions. Pent-up demand and return of foreign patients will partially offset the declining Covid-19 revenues. We are Neutral on the sector, with IHH, SILO and BCH as our top picks.
Equity Analysis /
Asia